SEARCH

SEARCH BY CITATION

References

  • 1
    Schmidt B. Prevention of IVH and BPD: International Randomized Placebo-Controlled Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP).Presented at Hot Topics in Neonatology Conference,Washington, DC,Dec 5, 2000.
  • 2
    Vohr BR, Wright LL & Dusick AM, et al.Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics 2000;105:12161226.
  • 3
    Wood NS, Marlow N & Costeloe K, et al.Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000;343:378384.
  • 4
    McGrath MM, Sullivan MC, Lester BM & Oh W. Longitudinal neurological follow-up in neonatal intensive care unit survivors with various neonatal morbidities. Pediatrics 2000;106:13971405.
  • 5
    Peterson BS, Vohr B, Staib & Lh, et al.Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000;284:19391947.
  • 6
    Hack M & Taylor HG. Perinatal brain injury in preterm infants and later neurobehavioral function. JAMA 2000;284:19731974.
  • 7
    Eriksson J, Forsen T & Tuomilehto J, et al.Fetal and childhood growth and hypertension in adult life. Hypertension 2000;36 (5):790794.
  • 8
    Jobe A. Overview for prevention of IVH—Why are <1 kg infants normal?Presented at Hot Topics in Neonatology Conference,Washington, DC,Dec 5, 2000.
  • 9
    Harrison H. The principles for family-centered neonatal care. Pediatrics 1993;92:643650.
  • 10
    Finer NN, Craft A & Vaucher YE, et al.Postnatal steroids: Short-term gain, long-term pain?J Pediatr 2000;137:913.
  • 11
    Lorenz JM. Survival of the extremely preterm infant in North America in the 1990s. Clin Perinatol 2000;27:255262.
  • 12
    Halliday HL. Clinical trials of postnatal corticosteroids: Inhaled and systemic. Biol Neonate 1999;76:2940.
  • 13
    Vermont Oxford Network 1998 Database Summary.Burlington, Vermont:Vermont Oxford Network,1999.
  • 14
    Murphy BP, Inder TE & Huppi PS, et al.Quantitative brain growth following treatment with dexamethasone for neonatal chronic lung disease [abstract]. Pediatr Res 2000;47:419A.
  • 15
    Shinwell ES, Karplus M & Reich D, et al.Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177F181.
  • 16
    Yeh TF, Yin YJ & Huang CC, et al.Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics 1998;101:E71E78.
  • 17
    O'Shea T, Kothadia J & Klinepeter K, et al.Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:1521.
  • 18
    Vohr BR, Phelps D & Wright LL, et al.Effects of neonatal interventions on retinopathy of prematurity (ROP) in extremely low birth weight (ELBW) survivors <1000 grams [abstract]. Pediatr Res 2000;47:327A
  • 19
    Halliday HL & Ehrenkranz RA. Delayed (>3weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2000: CD001145.
  • 20
    Stark AR, Carlo W & Bauer C, et al.Complications of early steroid therapy in a randomized controlled trial [abstract]. Pediatrics Suppl 1999;104:739A.
  • 21
    Soll RF & Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease [abstract]. Pediatr Res 1999;45:226A.
  • 22
    Ortiz LA, Quan A & Weinberg A, et al.Prenatal dexamethasone causes reduced glomerular number and hypertension in adult rats [abstract]. Pediatr Res 2000;47:450A.
  • 23
    Doyle LW. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 2000;98:137142.
  • 24
    Bakker JM, Kavelaars A & Kampuis PJ, et al.Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adults. J Immunol 2000;165:59325937.
  • 25
    Kamisuka MD, Williams MA & Nyberg DA, et al.Renal calicification: A complication of dexamethasone therapy in preterm infants with bronchopulmonary dysplasia. J Perinatol 1995;15:359363.
  • 26
    Banks BA, Merrill JD & Cnaan A, et al.Multiple courses of antenatal corticosteroids (ANCS): Association with increased mortality and early severe lung disease (ESLD) in preterm neonates [abstract]. Part 3. Pediatrics 1999;104 (3):739.
  • 27
    Kamphuis PJGH, Coiset G & Bakker JM, et al.Neonatal treatment with dexamethasone selectively reduces pituitary-adrenal responsiveness of rats to novelty stress in adulthood [abstract]. Pediatr Res 2000;47:71A.
  • 28
    Benesova O & Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989;28:8997.
  • 29
    National Institute of Health. Antenatal Corticosteroids Revisited: Repeat Courses.NIH Consensus Statement 2000,Bethesda, MD,Aug 1718;17:110.
  • 30
    French NP, Hagan R & Evans SF, et al.Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114121.
  • 31
    French NP, Hagan R & Evans S, et al.Repeated antenatal corticosteroids (CS): Behavior outcomes in a regional population of very preterm (VP, <33w) infants. [abstract]. Pediatr Res 1998:43:214A.
  • 32
    Kay HH, Bird IM & Coe CL, et al.Antenatal steroid treatment and adverse fetal effects: What is the evidence?J Soc Gynecol Investig 2000;7:269278.
  • 33
    Bhandari V & Brodsky NL. Repetitive doses of antenatal steroids (ANS) are associated with increased gastroesophageal reflux (GER) [abstract]. Pediatr Res 1999;45:186A.
  • 34
    del Moral T, Claure S & VanBuskirk S, et al.Antenatal steroids and incidence of ROP in ELBW infants [abstract]. Pediatr Res 2000;47:395A.
  • 35
    Taeusch HW. Glucocorticoid prophylaxis for respiratory distress syndrome: A review of potential toxicity. J Pediatr 1975:87:617623.
  • 36
    Weichsel ME. The therapeutic use of glucocorticoid hormones in the neonatal period: Potential neurological hazards. Ann Neurol 1977;2:364366.
  • 37
    Frank L. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: A cautionary note [letter]. Pediatrics 1991;88:413414.
  • 38
    Jobe A. Glucocorticoids in perinatal care: Misguided rockets?J Pediatr 2000;137:13.
  • 39
    Silverman WA. Where's the Evidence? Debates in Modern Medicine.New York:Oxford University Press,1998.
  • 40
    Silverman WA. Retrolental Fibroplasia: A Modern Parable.New York:Grune & Stratton,1980.
  • 41
    Stahlman MT. Ethical issues in the nursery: Priorities versus limits. J Pediatr 1990;116:167170.
  • 42
    Taylor RS. Postnatal steroid use among neonatologists: Survey results.Dec 2000. http://www.cheo.on.ca/rtaylor/PNSteroid-r.htm
  • 43
    Maisels J & S J Brown. Neonatal intensive care: Life at what cost?Pediatr News 1993;Jan:1,26.